Purpose: To assess the safety and the efficacy of sequential regimen chemotherapy of three cycles of fluorouracil, epirubicin, cyclophosphamide followed by three cycles of docetaxel (FEC-D) as adjuvant treatment for node - positive early stage breast cancer after curative resection.